Developing advanced animal models for respiratory and infectious diseases
Official title: Animal Models Core
Funded at Oklahoma State University Stillwater · NIH-10881696 · Data updated 2026-11-12
This study is working to improve how scientists test new treatments and vaccines for respiratory and infectious diseases, like COVID-19, by creating safer lab environments, which could eventually lead to better care for patients like you.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma State University Stillwater NIH-funded |
| Lab location | 1 site (Stillwater, United States) |
| Project start | July 5, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $191,154 |
| NIH project number | 5P30GM149368-02 |
| Project ID | NIH-10881696 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by respiratory infections or those at high risk for COVID-19.
✕Less likely to help
Patients with non-respiratory infectious diseases or those not affected by COVID-19 may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing animal models used to study respiratory and infectious diseases, particularly in the context of COVID-19. The project aims to expand existing facilities and capabilities to include advanced biosafety level 3 (ABSL-3) environments, which are crucial for safely conducting experiments with highly infectious agents. By providing state-of-the-art equipment and training for researchers, the project seeks to improve the understanding of disease mechanisms and the development of effective vaccines and treatments. Patients may benefit indirectly through advancements in therapies and vaccines that arise from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and treatments for respiratory and infectious diseases, including COVID-19.
How similar studies have gone: Previous research has shown success in using animal models to develop vaccines and treatments for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
Oklahoma State University Stillwater
Stillwater, United States Active
Researchers
- Principal investigator: Hinsdale, Myron E — Oklahoma State University Stillwater
- Study coordinator: Hinsdale, Myron E
Related research
Other NIH-funded projects on the same topics.
-
Iron and scar-forming cells in the lungs (IPF)
Researchers are exploring how iron in the lungs may drive the scarring seen in idiopathic pulmonary fibrosis and whether this could lead to new therapies.
-
Understanding how a calcium sensor helps Pseudomonas infections resist the immune system
This project looks at how the bacteria Pseudomonas aeruginosa uses a calcium sensor to survive and cause infections in people with conditions like cystic fibrosis.
-
ERK1/2 signaling and SARS-CoV-2 immune dysregulation in the lung
Aims to see if blocking ERK1/2 in immune cells can reduce dangerous lung inflammation from SARS-CoV-2 and boost antiviral defenses.
-
OADDL Testing Support for Vet-LIRN (Veterinary Network)
A veterinary diagnostic lab in Oklahoma will support national animal health surveillance and testing programs by handling clinical samples, animal feeds, environmental samples, and necropsies to help keep animal health and food safety safer.
-
How social life affects cognitive health in older adults in rural and urban areas
A study following older adults in rural and urban areas to see how social networks and daily activities relate to thinking skills over time.
-
Biophysical view of how enzymes work to help fight cancer
A scientist is studying how enzymes work on a deep, molecular level to help design better cancer drugs with fewer side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.